유럽의 AI 지원 의료 영상 시장(2025년)

Report Metadata

• Geographic scope: Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Modalities: CT, MRI, X ray/DR, Ultrasound, PET/Nuclear
• Clinical areas: Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General Diagnostic
• Applications: Early detection/triage; diagnostic accuracy & classification; workflow/efficiency; prognosis & treatment; image enhancement/dose; segmentation/feature extraction; integration across modalities
• Revenue streams: Hardware (factory attach CAPEX uplift), Software (fixed licenses incl. enterprise subscriptions), Service (implementation/validation/support), Cloud/Pay per Use (metered per scan)
• End use: Hospitals, Imaging Centers, Clinics, Teleradiology, Other providers

Report Summary

The Europe - AI assisted Medical Imaging Pulse report sizes and forecasts AI spend across CT, MRI, X ray/DR, Ultrasound, and PET/Nuclear for DE, FR, UK, IT, ES, RoE. It provides 2023-24 actuals and a 2025-2032 forecasts by modality, clinical area, application, revenue stream, end use organization, and AI technology-plus GTM Growth & Maturity, Ecosystem Collaboration, and Solution Adoption & Growth frameworks tailored to Europe.

This 88 page Markintel(TM) Pulse report from Marketstrat(TM) delivers a Europe only view of AI in medical imaging. Regional frameworks-GTM Growth & Maturity (vendor view), Ecosystem Collaboration Matrix, and Solution Adoption & Growth-translate evidence into sequencing, partnering, and pricing decisions. Country chapters for Germany, France, the UK, Italy, Spain, and RoE include GTM readiness, pricing fit, and tiered customer landscapes. Methodology reconciles a top down Europe spend model with bottom up attach rate x ASP engines by modality and country, weighted by regulatory filings, audited financials, licensed expert transcripts, and RWE.

Country reality: Germany pivots to modular SaaS by 2027; UK favors cloud/usage pricing; France prioritizes integration & compliance; Italy grows MR led AI via PNRR; Spain's case is backlog reduction; RoE clusters show strong retrofit potential.

Decision ready frameworks: GTM Growth & Maturity, Ecosystem Collaboration, Solution Adoption & Growth-all Europe level.

Who should use this report:

• OEM leadership (product, regional GMs, strategy)
• Specialist AI vendors & platforms (founders, sales leaders, partnerships)
• Provider networks (CIO/CMIO, radiology chairs, procurement)
• Investors & equity analysts (MedTech/HCIT)
• Consulting & advisory firms (GTM, pricing, diligence)

What decisions it supports (now/next quarter)

• Which solutions to bundle for enterprise/platform deals vs list in marketplaces.
• Pricing fit-term vs enterprise subscription vs usage based by country.
• Pilot to scale plans tied to procurement cadence and evidence expectations.
• Partner routes (OEM stores, PACS marketplaces, cloud exchanges) per country.

What's inside:

• Europe key numbers: totals and growth milestones through 2032.
• Breakdowns by modality, clinical area, application, revenue stream, end use, AI technology.
• Country chapters (DE, FR, UK, IT, ES, RoE) with: GTM readiness radar, country pricing matrix, tiered customer landscape, and forecast tables.
• Regional frameworks (Europe level):
  • GTM Growth & Maturity - vendor map
  • Ecosystem Collaboration Matrix (ECM)
  • Solution Adoption & Growth Matrix
• Methodology: dual lens model (top down reconciliation; bottom up attach rate x ASP), evidence weighting, QA checks.

Why buy this Pulse report:

• One coherent model: numbers reconcile across modality, country, application, and revenue stream.
• Evidence weighted: regulatory, financial and interview based signals are combined with clear confidence weights.
• Action oriented: frameworks translate data into sequencing, partnering, and pricing moves.
• Faster than a custom study: focused Europe scope you can use today.

Methods in brief:

• Dual lens architecture: top down Europe spend anchors totals; bottom up attach rate x ASP engines size each modality and country.
• Evidence pillars: CE MDR/UKCA filings, audited financials, licensed expert call transcripts, and peer reviewed or conference RWE.
• QA: numeric parity across tables/figures; documented source trail; second reader editorial check.

TABLE OF CONTENTS

SECTION 1 - EXECUTIVE SUMMARY

• What this Pulse Covers
• Key Numbers Snapshot (Europe)
• What's Driving Europe's Curve
• Where the Value Pools Form
• Country Outlook-Six Different Routes to Scale
• Near term Watchlist (Next 12-18 Months)
• What to do now (Insights -> Action)
  • OEMs
  • Pure plays
  • Providers & Networks
  • Investors

SECTION 2 - RESEARCH METHODOLOGY

• About this Pulse Report
• Scope & Segmentation
• Marketstrat's "Insights -> Action" Approach
• Dual lens Architecture
• Top down Market Funnel (Europe)
  • How it Works in the Model
• Bottom up Attach rate Flow (Europe)
• What we model for Each Country and Segment
• Evidence Confidence - Density vs Reliability (Europe)
  • Reading the Bubbles
• Regional Frameworks Included in this Pulse Report
• GTM Country Tools
• Quality Assurance & Governance
• Limitations & Mitigations

SECTION 3 - EUROPEAN MARKET ANALYSIS

• Market Overview & Analysis
  • Market Snapshot
  • Structural Demand Signals
  • Regulatory & Funding Landscape (2024-2028)
  • Market Segmentation 2032 (value share)
  • Competitive Heat Map (2024-26)
  • Execution Playbook (2024-2027)
  • Action-Oriented Recommendations
• European Market Estimates and Forecasts by Country (2023-2032, USD Mill)
  • Five Forces Shaping Adoption
  • Country Archetypes & What Sells
  • Near term Adoption Runway (2024-27)
  • Strategic Implications
  • Regulatory Velocity by Company - Europe
• Markintel Growth Maturity Matrix - Europe
  • Landscape Snapshot
  • Why the Quadrant Looks the Way it Does
  • Key Competitive Dynamics
  • Strategic Takeaways
  • Bottom Line
  • M&A Watchlist - Europe
  • Competitive Dataset - Europe
  • Growth & Maturity Highlights - Europe
• Markintel Ecosystem Collaboration Matrix (ECM) - Europe
  • Quadrant Commentary & European Illustrations
  • Action Checklist
• Markintel Solution Adoption & Growth Matrix - Europe
  • Quadrant Deep Dive
  • What Moves a Solution from One Box to the Next?
  • Strategic Guidance
• AI Attach Rate - Europe
  • OEM AI Attach Rate
  • Attach Rate Trends - Europe
  • AI Revenue Split - Factory vs Retrofit Attach -- Europe
• GTM at a Glance - Europe
  • Channel & Pricing Matrix (2025-2028)
  • GTM Readiness Radar - Europe
  • Tiered Customer Landscape (2032 View)
  • GTM Timeline (2025 -> 2028) - Europe
  • Adjacency Opportunity Radar (2026+) - Europe
  • Regulatory x Funding Heatmap - Europe
  • AI Imaging Whitespace Matrix - Europe
  • Fast Strategic Cues (2025 playbook)

SECTION 4 - GERMAN MARKET

• Market Overview - Germany
• Macro & Epidemiology
• Health system & Funding Landscape
• Regulatory & Evidence Pathway
• Competitive Landscape
• Strategic Takeaways & Recommendations
• German Market by Clinical Area
  • Forecast by Clinical Area (2023-2032, USD Mill)
  • Primary Growth Catalysts
  • Strategic Messages for Stakeholders
  • Key Takeaways
• German Market by Modality (2023-2032, USD Million)
  • Forecast by Modality (2023-2032, USD Mill)
  • Key Inflection by Modality
  • What's Driving Each Modality
  • Strategic Implications
• German Market by Revenue Stream (2023-2032, USD Million)
  • Forecast by Revenue Stream (2023-2032, USD Mill)
  • Revenue Streams and Drivers
  • Key Dynamics by Stream
  • Strategic Guidance
• German Market by Clinical Application (2023-2032, USD Million)
  • Forecast by Clinical Application (2023-2032, USD Mill)
  • What is Driving Each Bucket
  • Strategic Messages
  • Action Playbook
• German Market by End-Use Organization (2023-2032, USD Million)
  • Forecast by End-Use Organization (2023-2032, USD Mill)
  • Segments Review
  • Strategic Implications
• German Market by AI Technology (2023-2032, USD Million)
  • Forecast by AI Technology (2023-2032, USD Mill)
  • Germany - AI Imaging Market by Core Technology
  • Why Deep Learning Keeps the Lion's Share
  • Break-out Growth Themes
  • Strategic Playbook
• GTM at-a-Glance - Germany
  • Channel x Pricing Matrix
  • GTM Readiness Radar - Germany
  • Tiered Customer Landscape
  • GTM Timeline - Germany
  • Fast Strategic Cues

SECTION 5 - FRENCH MARKET

• Market Summary: France
  • Top line Snapshot - France
  • Key Market Dynamics
  • Strategic Takeaways
  • Top 3 Recommendations
  • French Market Speed scan - Market Analysis (2024-2032)
• French Market Estimates and Forecasts (2023-2032)
  • French Market by Clinical Area (2023-2032)
  • French Market by Modality (2023-2032)
  • French Market by Revenue Stream (2023-2032)
  • French Market by Clinical Application (2023-2032)
  • French Market by End-Use Organization (2023-2032)
  • French Market by AI Technology (2023-2032)
• GTM at a Glance - France
  • Channel x Pricing Matrix
  • GTM Readiness Radar - What Counts Most in France
  • GTM Timeline (2024-30) - France
  • Spend Potential by Customer Tier - France

SECTION 6 - UNITED KINGDOM MARKET

• Market Overview - United Kingdom
• UK Market Speed Scan
  • Scale & growth
  • Policy & funding
  • Demand triggers
  • Procurement routes
  • Competitive Field
  • Winning playbook 2024-27
• UK Market Estimates and Forecasts (2023-2032)
  • UK Market by Clinical Area (2023-2032)
  • UK Market by Modality (2023-2032)
  • UK Market by Revenue Stream (2023-2032)
  • UK Market by Clinical Application (2023-2032)
  • UK Market by End-Use Organization (2023-2032)
  • UK Market by AI Technology (2023-2032)
• GTM at a Glance - UK
  • Channel x Pricing Matrix
  • GTM Readiness Radar - UK
  • Fast Strategic Cues
  • Tiered Customer Landscape - UK
  • GTM Timeline (2024-29) - UK

SECTION 7 - ITALIAN MARKET

• Market Overview & Summary: Italy
  • What Makes Italy Unique in the EU Context
  • Strategic Takeaways
• Italian Market Estimates & Forecasts (2023-2032)
  • Italian Market by Clinical Area (2023-2032)
  • Italian by Modality (2023-2032)
  • Italian Market by Revenue Stream (2023-2032)
  • Italian Market by Clinical Application (2023-2032)
  • Italian Market by End-Use Organization (2023-2032)
  • Italian Market by AI Technology (2023-2032)
• GTM at a Glance - Italy
  • Channel x Pricing Matrix
  • Tiered Customer Landscape & Spend Potential (2032) - Italy
  • GTM Readiness Radar - Italy
  • GTM Timeline (2024-29) - Italy
  • Fast Strategic Cues

SECTION 8 - SPANISH MARKET

• Market Overview & Summary - Spain
• Strategic Takeaways
• Spanish Market Estimates and Forecasts (2023-2032)
  • Spanish Market by Clinical Area (2023-2032)
  • Spanish Market by Modality (2023-2032)
  • Spanish Market by Clinical Application (2023-2032)
  • Spanish Market by Revenue Stream (2023-2032)
  • Spanish Market by End-Use Organization (2023-2032)
  • Spanish Market by AI Technology (2023-2032)
• GTM at a Glance - Spain
  • GTM Readiness Radar - Spain
  • Channel x Pricing Matrix
  • Tiered Customer Landscape - Spain
  • GTM Timeline - Spain

SECTION 9 -REST OF EUROPE (ROE) MARKET

• Market Overview: Rest of Europe (ROE)
  • Size & trajectory
  • Why Growth Accelerates
  • Risks / Headwinds
• Strategic Takeaways
• Rest of European Market for AI in Medical Imaging (2023-2032)
  • Rest of European Market by Clinical Area (2023-2032)
  • Rest of European Market by Modality (2023-2032)
  • Rest of European Market by Revenue Stream (2023-2032)
  • Rest of European Market by Clinical Application (2023-2032)
  • Rest of European Market by End-Use Organization (2023-2032)
  • Rest of European Market by AI Technology (2023-2032)
• GTM at a Glance - Rest of Europe (ROE)
  • GTM Readiness Radar - ROE
  • Tiered Customer Landscape - ROE
  • GTM Timeline - ROE
  • Channel x Pricing Matrix
  • Adjacency-Opportunity Matrix (2026-2030)
  • Country-Cluster Framework & Strategic Playbook
  • White-Space Partnership Matrix
  • Regulatory Funding Heatmap (ROE Clusters)
  • Fast Strategic Cues